Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,240 across all filing types
Latest filing 2025-01-21 Board/Management Inform…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a notification to stock exchanges about an upcoming Board Meeting scheduled for January 28, 2025. It mentions that the Board will consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2024, and a proposal for issuance of Sweat Equity Shares. The document is an intimation of a Board Meeting and does not contain the actual financial results or detailed report. It is a regulatory announcement pursuant to SEBI regulations about the meeting and related agenda items. The document length is short (2672 characters) and it serves as a notice rather than a full report or detailed filing. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2025-01-21 English
Enclosed herewith please find attached the Intimation regarding the completion of service of Mr. Dinesh Shetty, General Manager of the Company in accordance with the Company''s superannuation policy.
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the completion of service of a senior management personnel, Mr. Dinesh S. Shetty. It references compliance with SEBI Listing Regulations and provides details pursuant to Regulation 30 and a SEBI circular. The content focuses on management change notification rather than financial results, audit, or other report types. The document length is short (2621 characters) and is a formal announcement of a management change, not a report or presentation. Therefore, it fits the category of Board/Management Information (MANG).
2025-01-16 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges about the completion of service of a senior management personnel, Mr. Dinesh S. Shetty, as General Manager. It references compliance with SEBI Listing Regulations and includes details pursuant to a SEBI circular. The content is about management personnel change and does not contain financial data, audit information, or report publication. It is an announcement of a change in senior management, fitting the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming it is not a full report or other filing type.
2025-01-16 English
Updates
Share Issue/Capital Change Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the allotment of shares under an Employee Stock Options Plan (ESOP). It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations related to share-based employee benefits. The document includes specifics such as share certificate numbers, ISIN, exercise price, premium, lock-in period, and confirmation that the shares rank pari-passu with existing shares. There is no financial performance data, earnings information, or management discussion. The document is an announcement of a capital change due to ESOP share allotment, which fits the category of Share Issue/Capital Change (SHA). The document length is under 5,000 characters and contains detailed information about the share allotment, not just a notice of a report publication or a regulatory filing. Therefore, the appropriate classification is SHA with high confidence.
2025-01-07 English
We like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on January 07, 2025, has approved the allotment of 4,000 equity shares of the face value of Re. ....
Share Issue/Capital Change Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the allotment of shares under the company's Employee Stock Options Plan (ESOP) 2019. It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations related to share-based employee benefits. The document includes specifics such as share certificate numbers, ISIN, exercise price, premium, lock-in period, and confirmation that the shares rank pari-passu with existing shares. There is no financial statement or comprehensive financial analysis present. The document is an announcement of a capital change due to ESOP share allotment, which fits the category of Share Issue/Capital Change (SHA). The document length is under 5,000 characters, but it contains substantive information about the share allotment, not merely a notice of report publication or certification. Therefore, the correct classification is SHA with high confidence.
2025-01-07 English
Please find enclosed herewith intimation regarding the change of name of Registrar and Transfer Agent.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) informing them about a change in the name of the company's Registrar and Transfer Agent (RTA). It references compliance with SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations. The content is a regulatory disclosure about a change in service provider name, not a financial report, earnings release, or management discussion. The document length is short (1513 characters), and it is an announcement of a corporate administrative change. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.